At BeOne, our commitment to patients goes beyond innovation. We believe in the power of partnerships to elevate patient voices, expand access, and co-create solutions that improve lives. This #BreastCancerAwarenessMonth, we’re spotlighting key patient advocacy partners, including Living Beyond Breast Cancer, Tigerlily Foundation, and Susan G. Komen, alongside the broader community working every day to support and empower people impacted by breast cancer. Let’s learn, share, and advocate together. #BeOneAgainstCancer #BreastCancer #BeOneVoice
BeOne Medicines
Biotechnology Research
Cambridge, Massachusetts 217,498 followers
Cancer has no borders. Neither do we.
About us
BeOne Medicines is a global oncology company that is discovering and developing innovative treatments that are more affordable and accessible to cancer patients worldwide. With a portfolio spanning hematology and solid tumors, BeOne is expediting development of its diverse pipeline of novel therapeutics through its internal capabilities and collaborations. With a growing global team of more than 11,000 colleagues spanning six continents, the Company is committed to radically improving access to medicines for far more patients who need them. To learn more about BeOne, please visit www.beonemedicines.com and follow us on LinkedIn, X, Facebook and Instagram. We all share the responsibility to report adverse events observed with our products so that they may be investigated, actioned, and communicated accordingly. To report an adverse event or side effect, please talk to your healthcare provider and contact us here: https://beonemedicines.com/contact-us/report-adverse-event/.
- Website
-
https://beonemedicines.com/
External link for BeOne Medicines
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Cambridge, Massachusetts
- Type
- Public Company
- Founded
- 2010
- Specialties
- oncology, hematology, cancer treatment, solid tumor, and targeted therapy
Locations
Employees at BeOne Medicines
Updates
-
The deadlines to apply for BeOne Medicines 2026 – 2027 Fellowships are closing soon! Our postgraduate and postdoctoral programs offer tailored training, practical experience, and meaningful mentorship to graduates searching for roles in Regulatory Affairs, Safety, Medical Writing, and Medical Affairs. Don’t miss the chance to kickstart your career at a company that’s reimagining cancer treatment and accelerating innovative medicines. Apply here: https://lnkd.in/gqVmsyJJ #TeamBeOne #Careers #BeOneAgainstCancer
-
-
As Blood Cancer Awareness Month comes to a close, we continue to honor the patients, families, caregivers, advocates, and clinicians who inspire us every day. At BeOne, our commitment doesn’t end in September. From advancing science with purpose, to expanding access across geographies, to keeping patients at the center of all we do — we are working together to help close the gaps in blood cancer care. Watch this short video featuring our leaders from around the world, reflecting on how we’re making an impact — today, tomorrow, and every day. #BloodCancerAwareness #PatientsFirst
-
BeOne Medicines reposted this
I was honored to share insights from our journey at #BeOneMedicines in transforming Global Clinical Operations at #DPHARM2025 last week. I am so proud that we have built a global, lean, agile and scalable internal model focused on driving operational excellence, with the goal of bringing innovative medicines to more patients around the world faster. It was so wonderful to connect with colleagues across the industry who share our passion and vision. #innovation #GlobalHealth #ClinicalResearch #BeOneMedicines
-
-
Meet Vanessa Morais, Quality Senior Manager, who’s personal experience with cancer provides a unique perspective within her role. We’re proud to be part of #TeamBeOne, who takes a stand against cancer and strives to challenge the status quo to deliver science previously thought to be impossible. Interested in joining us? Visit https://ow.ly/xT2950X29Ct. #Oncology #PatientsFirst
-
-
For Chronic Lymphocytic Leukemia (CLL) patients, the phrase 'watch and wait' can create anxiety and uncertainty during active monitoring. To dispel this anxiety, this #BloodCancerAwarenessMonth we are committed to ensuring patients with CLL and their carers have access to clear and credible information. Collaborating with our panel of experts, including leading healthcare professionals, CLL patients and advocates, Jan Geissler, Christina Karamanidou, Jana Pelouchova, Lydia Scarfo and Peter Haggert, we are working to address the pressing challenges faced by those living with CLL. As leading contributors to the CLL Call-To-Action Report, the panel explored key areas of unmet need, and innovative approaches to care, emphasizing the emotional and practical support required to navigate active monitoring. Watch the full discussion to hear about how you can take actionable steps to improve the lives of people living with CLL: https://lnkd.in/gcSWTd2R #NavigatingCLLTogether #BeOneAgainstCancer #CLL, #BloodCancerAwarenessMonth
Improve the lives of people living with CLL
-
BeOne Medicines reposted this
Ensuring equity and access to innovation in oncology as BeOne Medicines’ SVP, Head of Europe
Today, I had the privilege of welcoming many valued guests to a networking event that felt both symbolic and deeply personal. Although I only joined BeOne in January this year, I’m inspired by the remarkable journey of the organization since 2018, when three colleagues in Basel laid the first stone of what is today our European office and company domicile, building the foundation for what comes next. Calling Basel our home, a city at the heart of Europe’s life sciences ecosystem, I’m struck by how much vision, hard work, and collaboration have shaped this journey and brought us to where we are today. The conversations yesterday reminded me that progress in oncology is never a solo effort. It takes scientists who imagine, governments who enable, clinicians who care, caregivers who support, advocates who amplify, and—above all—patients who inspire us every day. To everyone who joined us, thank you. Your commitment and partnership make me optimistic about what we can achieve when we truly act as one. #BeOne #Oncology #Collaboration Swiss Biotech Association Switzerland Global Enterprise Krebsliga beider Basel (KLBB) Basel Area Business & Innovation Kanton Basel-Stadt
-
-
We believe innovation matters only when it reaches patients. At the World Knowledge Forum 2025 in Seoul, Adam Roach, our SVP & Head of JAPAC, presented: “Innovation That Reaches Patients: A New Oncology Access and Speed Strategy for K-Bio.” Key themes: -Integration across R&D, clinical development, and manufacturing -Execution that delivers medicines faster, to more patients around the globe -Partnerships that expand access in both advanced and emerging markets 📍 At BeOne, we’re redefining innovation—not just through science, but by building systems that ensure patients everywhere can benefit. #WorldKnowledgeForum #TeamBeOne #PatientAccess #OncologyInnovation #BeOneInnovator
-
-
"When my patients hear the word 'cancer,' the shutters come down." For Hematologist Dr. Ben Kennedy, effective communication is essential in helping patients navigate the complexities of Chronic Lymphocytic Leukemia (CLL). The impact of a CLL diagnosis can be minimized when a patient truly understands CLL and the support they can receive. "Without good, trusted information, patients can become overwhelmed with worry." The way healthcare providers explore and discuss information significantly influences how patients feel when they leave the consultation room—either empowered, ready to take action and thrive, or worried, scared, and unsure of their future. Explore Dr. Kennedy's insights gained from working with CLL patients and discover our Call-to-Action Report, developed in partnership with CLL Advocates Network, to highlight the unmet needs in their care: https://ow.ly/uLEY50WXNYW #NavigatingCLLTogether #CLL #BeOneAgainstCancer
Navigating CLL together
-
BeOne was honored to host industry leaders and experts at our Hopewell, NJ, facility for BioNJ’s 2025 Manufacturing Summit. We explored key industry topics - from supply chain and workforce challenges to how cutting-edge technologies and advanced analytics are transforming biopharma manufacturing. The day wrapped with a tour of our state-of-the-art biologics manufacturing and clinical R&D facility, giving attendees a behind-the-scenes look at innovation in action. #BeOneInnovator #BeOneAgainstCancer #BioNJ
-